Refixia

Nonacog Beta Pegol (N9-GP) · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Refixia, covering 2023-12-29 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Post-marketing Surveillance (Use Result Surveillance) With Refixia®